Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
substance p (1 trial)
Diabetes Mellitus (Phase 1)
Diabetes Mellitus, Type 1 (Phase 1)
Trials (1 total)
Trial APIs (1 total)